American Journal Of Gastroenterology - Author Podcasts
A 12-week, randomized controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 0:35:31
- Mais informações
Informações:
Sinopse
AJG Journal co-editor Dr. Paul Moayyedi talks with William D. Chey, MD, FACG and Satish Rao, MD, PhD, FACG about to two randomized controlled trials on linaclotide in irritable bowel syndrome (IBS) published in the December issue of The American Journal of Gastroenterology. The phase 3 trials report that this new therapy significantly reduces constipation and abdominal pain associated with some kinds of IBS.
